{
  "pmcid": "11745596",
  "sha256": "e3e6512d4ed8d2754aa2ab0b17b36aa213af0cfaa7d98711867de49211f4308c",
  "timestamp_utc": "2025-11-09T23:19:50.020543+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.816176470588236,
    "reading_ease": 24.505294117647082,
    "word_count": 272
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Cost-Effectiveness of Dual Hypothermic Oxygenated Machine Perfusion in DCD Liver Transplantation: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients were randomised to receive a DCD liver preserved with either DHOPE or SCS"
      },
      "Participants": {
        "score": 2,
        "evidence": "The trial took place in three Dutch liver transplant centers."
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients were randomised to receive a DCD liver preserved with either DHOPE or SCS"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses the cost-effectiveness of dual hypothermic oxygenated machine perfusion (DHOPE) versus static cold storage (SCS) in donation after circulatory death (DCD) liver transplantation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the cost-effectiveness of DHOPE, evaluated by total medical costs up to one year posttransplant."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Patients and organ procurement teams were blinded to group allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 119 patients were randomised: 60 to DHOPE and 59 to SCS."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The mean total cost per patient was €110,794 for DHOPE and €126,221 for SCS, with significant reductions in intensive care costs (28.4%) and nonsurgical interventions (24.3%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "DHOPE-DCD trial; ClinicalTrials.gov number, NCT02584283"
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was funded by national healthcare bodies"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}